MedPath

Validation of ultrahigh field (7 Tesla) MRI with whole mount pathology in rectal cancer

Recruiting
Conditions
rectal cancer
10027655
Registration Number
NL-OMON48569
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

* Informed consent for PLCRC;
* Informed consent for the use of clinical data
* Informed consent for future studies within PLCRC;
* Eligible for neoadjuvant radiotherapy;
* Eligible for rectal surgery by Total Mesorectal Excision (either Low Anterior Resection, Abdominoperineal Resection or Hartmann resection).

Exclusion Criteria

* Patients with distant metastasis requiring surgery between chemoradiation and rectal surgery;
* MRI contraindications according to the MR safety protocol of the imaging division of the UMC Utrecht.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath